Alpha synuclein aggregation: is it the toxic gain of function responsible for neurodegeneration in Parkinson's disease?
- 30 September 2001
- journal article
- review article
- Published by Elsevier in Mechanisms of Ageing and Development
- Vol. 122 (14) , 1499-1510
- https://doi.org/10.1016/s0047-6374(01)00283-4
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- What causes the build-up of ubiquitin-containing inclusions in Parkinson’s disease?Mechanisms of Ageing and Development, 2000
- Fibrils Formed in Vitro from α-Synuclein and Two Mutant Forms Linked to Parkinson's Disease are Typical AmyloidBiochemistry, 2000
- Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine SystemNeuron, 2000
- Degradation of α-Synuclein by ProteasomeJournal of Biological Chemistry, 1999
- Synucleins in synaptic plasticity and neurodegenerative disordersJournal of Neuroscience Research, 1999
- α-Synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease β-amyloid plaque coresNeuroscience Letters, 1999
- A Wide Variety of Mutations in the Parkin Gene Are Responsible for Autosomal Recessive Parkinsonism in EuropeHuman Molecular Genetics, 1999
- Synthetic filaments assembled from C‐terminally truncated α‐synucleinFEBS Letters, 1998
- Phospholipase D Stimulates Release of Nascent Secretory Vesicles from the trans-Golgi NetworkThe Journal of cell biology, 1997
- The possible relation of glutathione, melanin and 1-methyl-4-phenyl-1,2,5,6-tetra-hydropyridine (MPTP) to Parkinson's diseaseBiochemical Pharmacology, 1984